MicroPort Orthopedics Welcomes C. Lowry Barnes, M.D. to Leadership Team as Medical Director

Leading Orthopedic Surgeon joins organization’s leadership team to advance continued growth and innovation in the medical device industry

MicroPort Orthopedics, a global leader in orthopedic devices and technologies, today announces that C. Lowry Barnes, MD, Chair of Orthopaedics at the University of Arkansas for Medical Sciences Health, has officially joined the company’s leadership team as Medical Director.
Dr. Barnes is a board-certified, fellowship-trained total joint surgeon with a special interest in hip and knee replacement surgery. His extensive expertise as an innovative thought leader and educator has greatly influenced the global orthopedic industry. Dr. Barnes has served in many leadership positions across the orthopedic industry, most recently as the President of the American Association of Hip and Knee Surgeons (AAHKS). He is also on the editorial boards of many scientific journals and serves as Editor for The Journal of Surgical Orthopaedic Advances (JSOA).
MicroPort Orthopedics is excited to benefit from Dr. Barnes’ expertise to further itself as a leader in the medical device industry. Dr. Barnes was very involved with MicroPort’s predecessor company and was a design surgeon for many of its implants including the Evolution® Knee, the highly successful medial pivot knee system. In his new and expanded role as Medical Director, Dr. Barnes will play a key role in the strategic decision-making and vision of the company, including medical education and training, clinical research, product development, surgeon relations, and same-day surgical procedures around the world.
“I have enjoyed working with the leadership team at MicroPort, and I look forward to engaging with their international sales team as we develop a high-touch, high tech approach to surgeon engagement. The opportunity to expand my role as Medical Director will allow for accelerated progress in innovation, leadership, and education – further establishing MicroPort as a leader in the medical device industry,” said Dr. Barnes.
“We are excited to announce that Dr. Barnes will be serving as MicroPort Orthopedics’ Medical Director. Adding a knowledgeable and committed surgeon like Dr. Barnes is yet another way that MicroPort is prioritizing its advancement in the orthopedic device space, and we look forward to the expertise and leadership that he brings to the organization,” said Benny Hagag, President of MicroPort Orthopedics.

Hot this week

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.